Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
Total Liabilities ₹8,778 Cr₹7,834 Cr₹6,496 Cr₹4,086 Cr

What is the latest Total Liabilities ratio of GLAND PHARMA ?

The latest Total Liabilities ratio of GLAND PHARMA is ₹8,778 Cr based on Mar2023 Consolidated results.
Year Total Liabilities
Mar2023₹8,778 Cr
Mar2022₹7,834 Cr
Mar2021₹6,496 Cr
Mar2020₹4,086 Cr

How is Total Liabilities of GLAND PHARMA Trending?

Years Total Liabilities % Change
Mar2023 ₹8,778 Cr
12.05
Mar2022 ₹7,834 Cr
20.59
Mar2021 ₹6,496 Cr
58.98
Mar2020 ₹4,086 Cr -

Compare Total Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,510.1 Cr 0.9% 1% 32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.9%

1%

32.4%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses